Liberate International for SUIResults expected around August 2019 for the international study with 99 participants.Positive results will be a catalyst for the SP barring any requirements for additonal follow ups. I am quite optimistic since Viveve would not be wasting cash on parallel tests if there was not high confidence that the outcome will be positive.
It is possible for an early release of partial results although I am not sure if they set up the analytical committee to do that. This would be a risk of not having a core position if you are trying to time the rally. Certainly the lack of news is positive since if there were negative outcomes then the program would have been halted.
The results for the International test will basically be the precursor for the US testing, and while the results there will be more comprehensive the outcome can be projected with more confidence. Meanwhile clearances can be put into place and now there will be more than double the revenue potential for clinics since there may be a stigma for the non-SUI application whereas everyone can relate empathetically to the SUI appilcation. I believe these two applications may leverage one another so 1 +1 = 3 but time will tell.
It will also be an easier sell for the health care providers to pay for the procedure. We need some good news in August since gaining profitability will not be possible while these tests are being performed.